Khalid Ibrahim, D. and Akram Yahya, N. 2023. Effects of Epigallocatechin-3-Gallate (EGCG) in Diabetes Mellitus as a DYRK1A inhibitor. Iraqi Journal of Pharmacy. 20, 2 (Dec. 2023), 168–173. DOI:https://doi.org/10.33899/iphr.2023.141712.1048.